Kevin Tan - 02 Dec 2021 Form 4 Insider Report for SELECTA BIOSCIENCES INC (RNAC)

Role
Chief Financial Officer
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Kevin Tan
Issuer symbol
RNAC
Transactions as of
02 Dec 2021
Net transactions value
+$15,126
Form type
4
Filing time
06 Dec 2021, 15:25:46 UTC
Previous filing
22 Sep 2021
Next filing
05 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SELB Common Stock Purchase $15,126 +5,000 $3.03 5,000 02 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $3.02 to $3.0293. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.